Combined impact of adiponectin and retinol-binding protein 4 on metabolic syndrome in elderly people: The Korean longitudinal study on health and aging

Obesity

Volumn 18, Issue 4, 2010, Pages 826-832

  Lim, Soo ^a,b   Yoon, Ji W ^b   Choi, Sung H ^a,b   Park, Young J ^a,b   Lee, Jung J ^a   Park, Joon H ^a   Lee, Seok B ^a   Kim, Ki W ^a   Lim, Jae Young ^a   Kim, Young Bum ^c   Park, Kyong S ^b   Lee, Hong K ^b   Cho, Sung I ^d   Jang, Hak C ^a,b  

^a Seoul National University Bundang Hospital   (South Korea)

^b Seoul National University College of Medicine   (South Korea)

^c HARVARD MEDICAL SCHOOL   (United States)

^d Seoul National University   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

ADIPONECTIN; PLASMA RETINOL BINDING PROTEIN;

ABDOMINAL FAT; AGE; AGED; ARTICLE; BLOOD; FEMALE; HUMAN; INSULIN RESISTANCE; KOREA; LONGITUDINAL STUDY; MALE; METABOLIC SYNDROME X; METABOLISM; PHYSIOLOGY; PREVALENCE;

ABDOMINAL FAT; ADIPONECTIN; AGE FACTORS; AGED; AGED, 80 AND OVER; FEMALE; HUMANS; INSULIN RESISTANCE; KOREA; LONGITUDINAL STUDIES; MALE; METABOLIC SYNDROME X; PREVALENCE; RETINOL-BINDING PROTEINS, PLASMA;

EID: 77950188054     PISSN: 19307381     EISSN: 1930739X     Source Type: Journal    
DOI: 10.1038/oby.2009.232     Document Type: Article

References (30)

1. Ford ES, Giles WH, Mokdad AH. Increasing prevalence of the metabolic syndrome among u.s. Adults. Diabetes Care 2004;27:2444-2449.
2. Lim S, Park KS, Lee HK, Cho SI. Changes in the characteristics of metabolic syndrome in Korea over the period 1998-2001 as determined by Korean National Health and Nutrition Examination Surveys. Diabetes Care 2005;28:1810-1812.
3. Ford ES, Giles WH, Dietz WH. Prevalence of the metabolic syndrome among US adults: findings from the third National Health and Nutrition Examination Survey. JAMA 2002;287:356-359.
4. Cameron AJ, Shaw JE, Zimmet PZ. The metabolic syndrome: prevalence in worldwide populations. Endocrinol Metab Clin North Am 2004;33:351-375, table of contents.
5. Blake DR, Meigs JB, Muller DC et al. Impaired glucose tolerance, but not impaired fasting glucose, is associated with increased levels of coronary heart disease risk factors: results from the Baltimore Longitudinal Study on Aging. Diabetes 2004;53:2095-2100.
6. Hofman A, Breteler MM, van Duijn CM et al. The Rotterdam Study: objectives and design update. Eur J Epidemiol 2007;22:819-829.
7. Rockwood K, Tan M, Phillips S, McDowell I. Prevalence of diabetes mellitus in elderly people in Canada: report from the Canadian Study of Health and Aging. Age Ageing 1998;27:573-577.
8. Kalmijn S, Foley D, White L et al. Metabolic cardiovascular syndrome and risk of dementia in Japanese-American elderly men. The Honolulu-Asia aging study. Arterioscler Thromb Vasc Biol 2000;20:2255-2260.
9. Wang J, Ruotsalainen S, Moilanen L et al. The metabolic syndrome predicts cardiovascular mortality: a 13-year follow-up study in elderly non-diabetic Finns. Eur Heart J 2007;28:857-864.
10. Heron M. Deaths: leading causes for 2004. Natl Vital Stat Rep 2007;56:1-95.
11. Hanley AJ, Wagenknecht LE. Abdominal adiposity and diabetes risk: the importance of precise measures and longitudinal studies. Diabetes 2008;57:1153-1155.
12. Wagenknecht LE, Langefeld CD, Scherzinger AL et al. Insulin sensitivity, insulin secretion, and abdominal fat: the Insulin Resistance Atherosclerosis Study (IRAS) Family Study. Diabetes 2003;52:2490-2496.
13. Yang Q, Graham TE, Mody N et al. Serum retinol binding protein 4 contributes to insulin resistance in obesity and type 2 diabetes. Nature 2005;436:356-362.
14. Graham TE, Yang Q, Blüher M et al. Retinol-binding protein 4 and insulin resistance in lean, obese, and diabetic subjects. N Engl J Med 2006;354:2552-2563.
15. Hu E, Liang P, Spiegelman BM. AdipoQ is a novel adipose-specific gene dysregulated in obesity. J Biol Chem 1996;271:10697-10703.
16. Matsuzawa Y, Funahashi T, Kihara S, Shimomura I. Adiponectin and metabolic syndrome. Arterioscler Thromb Vasc Biol 2004;24:29-33.
17. Polonsky KS. Retinol-binding protein 4, insulin resistance, and type 2 diabetes. N Engl J Med 2006;354:2596-2598.
18. Korea National Statistical Office. STAT-Korea, Census, (2003).
19. Vaché C, Rousset P, Gachon P et al. Bioelectrical impedance analysis measurements of total body water and extracellular water in healthy elderly subjects. Int J Obes Relat Metab Disord 1998;22:537-543.
20. Matthews DR, Hosker J P, Rudenski AS et al. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985;28:412-419.
21. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III). JAMA 2001 285 2486-2497.
22. WHO West Pacific Region. The Asia-Pacific Perspective: redefining obesity and its treatment. International Obesity Task Force 2000;2:15-21.
23. Lim S, Choi SH, Jeong IK et al. Insulin-sensitizing effects of exercise on adiponectin and retinol-binding protein-4 concentrations in young and middle-aged women. J Clin Endocrinol Metab 2008;93:2263-2268.
24. Lim S, Koo BK, Cho SW et al. Association of adiponectin and resistin with cardiovascular events in Korean patients with type 2 diabetes: the Korean atherosclerosis study (KAS): a 42-month prospective study. Atherosclerosis 2008;196:398-404.
25. Choi SH, Kwak SH, Youn BS et al. High plasma retinol binding protein-4 and low plasma adiponectin concentrations are associated with severity of glucose intolerance in women with previous gestational diabetes mellitus. J Clin Endocrinol Metab 2008;93:3142-3148.
26. Janke J, Engeli S, Boschmann M et al. Retinol-binding protein 4 in human obesity. Diabetes 2006;55:2805-2810.
27. Yao-Borengasser A, Varma V, Bodles AM et al. Retinol binding protein 4 expression in humans: relationship to insulin resistance, inflammation, and response to pioglitazone. J Clin Endocrinol Metab 2007;92:2590-2597.
28. Serra-Prat M, Alfaro SR, Palomera E et al. Relationship between ghrelin and the metabolic syndrome in the elderly: a longitudinal population-based study. Clin Endocrinol (Oxf) 2009;70:227-232.
29. Qiao Q. Comparison of different definitions of the metabolic syndrome in relation to cardiovascular mortality in European men and women. Diabetologia 2006;49:2837-2846.
30. Deurenberg-Yap M, Deurenberg P. Is a re-evaluation of WHO body mass index cut-off values needed? The case of Asians in Singapore. Nutr Rev 2003;61:S80-S87.